Zydus Lifesciences Q2 Results Live : Zydus Lifesciences declared their Q2 results on 12 Nov, 2024, reporting a notable increase in topline revenue by 19.87% year-over-year (YoY). However, compared to the previous quarter, the company experienced a decline in revenue by 15.63% and a significant profit decrease of 35.83%.
In a deeper analysis, the Selling, General & Administrative expenses showed a slight decline of 0.49% quarter-over-quarter (q-o-q) but reflected a substantial increase of 16.78% YoY. This trend indicates rising operational costs that may affect future profit margins.
Despite the quarterly challenges, Zydus Lifesciences reported an operating income increase of 34.41% YoY, though it was down by 37.57% q-o-q. The earnings per share (EPS) stood at ₹9.06 for Q2, marking a 14.36% increase YoY.
Zydus Lifesciences has had a mixed performance in the stock market, recording a -3.92% return in the last week and -3.45% return over the last six months. However, the company is showing a positive year-to-date return of 37.8%.
The company's current market capitalization is ₹95,567.08 Cr, with a 52-week high of ₹1324.3 and a low of ₹618.85. This indicates considerable volatility and potential investment opportunities in the stock.
As of 13 Nov, 2024, analysts are divided on Zydus Lifesciences' performance outlook. Out of 27 analysts, 3 have given a Strong Sell rating, 6 a Sell rating, 10 a Hold rating, 5 a Buy rating, and 3 a Strong Buy rating. The consensus recommendation as of this date is to Hold, reflecting cautious optimism among market watchers.
Zydus Lifesciences Financials
| Period | Q2 | Q1 | Q-o-Q Growth | Q2 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 5237 | 6207.5 | -15.63% | 4368.8 | +19.87% |
| Selling/ General/ Admin Expenses Total | 879.2 | 883.5 | -0.49% | 752.9 | +16.78% |
| Depreciation/ Amortization | 233.6 | 215.3 | +8.5% | 184.2 | +26.82% |
| Total Operating Expense | 4054.6 | 4313.6 | -6% | 3489.1 | +16.21% |
| Operating Income | 1182.4 | 1893.9 | -37.57% | 879.7 | +34.41% |
| Net Income Before Taxes | 1270.9 | 1899.7 | -33.1% | 1007.2 | +26.18% |
| Net Income | 911.2 | 1419.9 | -35.83% | 800.7 | +13.8% |
| Diluted Normalized EPS | 9.06 | 14.11 | -35.81% | 7.92 | +14.36% |
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
MoreLess